免疫治疗中的siglecs:当前的临床景观和前景
Abhinav Purohit1, Ishaan Joshi1, Pratik S Bhojnagarwala2
1Department of Biological Sciences, Indian Institute of Science Education and Research (IISER), Bhopal, MP 462066, India.
Trends in pharmacological sciences
|December 9, 2025
概括
西格莱克,免疫调节剂,在癌症和自身免疫中显示出治疗前景. 本综述探讨了Siglec向免疫疗法,重点关注治疗机制,安全性和疗效.
科学领域:
- 免疫学 免疫学 免疫学
- 葡萄糖生物学 葡萄糖生物学
- 治疗开发的治疗方法
背景情况:
- 锡格莱克 (酸结合性免疫球蛋白类讲蛋白) 是通过甘氨酸识别的免疫信号和恒温的关键调节者.
- 它们在免疫调节中的重要作用具有尚未探索的治疗潜力.
- 抗体工程和甘氨酸生物学的最新进展为治疗应用阐明了Siglec-ligand相互作用.
研究的目的:
- 审查Siglec向免疫疗法的临床前和临床进展.
- 强调这些新兴疗法的机制,安全性和有效性.
- 提出一个转化框架,以加速基于Siglec的治疗开发.
主要方法:
- 临床前研究的文献综述.
- 对最近临床试验数据的分析.
- 对Siglec-ligand相互作用机制的评估.
主要成果:
- 针对Siglec的免疫疗法在调节癌症和自身免疫性疾病的免疫抑制方面表现有前途.
- 目前的临床试验主要针对Siglec-2和Siglec-3,重点关注血液性恶性瘤.
- 进展突出了基于Siglec的策略在更广泛的免疫疗法应用中的潜力.
结论:
- 针对Siglec的免疫疗法在治疗癌症和自身免疫性疾病方面是一个有前途的前沿.
- 需要进一步的研究和翻译努力,才能充分实现Siglecs的治疗潜力.
- 一个结构化的框架可以加速基于Siglec的免疫疗法的开发和临床转化.
相关概念视频
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K